108 related articles for article (PubMed ID: 6460200)
1. [Involuntary movements as a complication of treatment of extrapyramidal disorders with L-dopa].
Friedman A; Markowa E
Neurol Neurochir Pol; 1981; 15(4):437-40. PubMed ID: 6460200
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutical approach to involuntary movements (author's transl)].
Allain H; Sabouraud O
Sem Hop; 1979 Feb 8-15; 55(5-6):262-4. PubMed ID: 219537
[TBL] [Abstract][Full Text] [Related]
3. [Dyskinesia caused by L-DOPA].
Derkinderen P; Vidailhet M
Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S92-101. PubMed ID: 12690668
[TBL] [Abstract][Full Text] [Related]
4. A blinded study of the suppressibility of involuntary movements in Huntington's chorea, tardive dyskinesia, and L-dopa-induced chorea.
Walters AS; McHale D; Sage JI; Hening WA; Bergen M
Clin Neuropharmacol; 1990 Jun; 13(3):236-40. PubMed ID: 2141544
[TBL] [Abstract][Full Text] [Related]
5. Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.
Warren Olanow C; Kieburtz K; Rascol O; Poewe W; Schapira AH; Emre M; Nissinen H; Leinonen M; Stocchi F;
Mov Disord; 2013 Jul; 28(8):1064-71. PubMed ID: 23630119
[TBL] [
